Аннотация:
The results of examinations and treatment of 349 patients with uterine myoma are analyzed. The patients were divided into 3 groups by the type of uterine myoma and clinical effi ciency of FUS therapy. Noninvasive dehydration of typical uterine myomas with edemas was used for extending the potentialities of MRgFUS and improvement of its results. Noninvasive lymph drainage was carried out in 42 patients with typical uterine myomas with stromal edemas. Dehydration led to shrinkage of the myoma nodule (by 20-40[%]) and attenuation of MR signal (by 50±15 U) in 85.7[%] (36) cases. Checkups 1, 3, 6, and 12 months after MRgFUS showed lesser intensity of uterine hemorrhages (according to PBAC tables), stable pain alleviation, and improvement of the quality of life (according to questionnaires).
Batarshina O.I.
Sidorova I.S.
Baranov I.I.
Stepanov A.V.
Ageev M.B. Mikhail B.
Kurashvili Y.B. Yu. B
V.I. Kulakov Center of Obstetrics, Gynecology, and Perinatology
Первый МГМУ им. И.М. Сеченова МЗ РФ
I.M. Sechenov First Moscow State Medical University
Radiopreparat
MRgFUS: New potentialities and better results of therapy
Текст визуальный электронный
Архив акушерства и гинекологии им. В.Ф. Снегирева
Eco-Vector
Т. 2, № 3 С. 8-12
2015
миома матки
uterine myoma
неинвазивная дегидратация
noninvasive dehydration
типичная миома матки с отеком
typical uterine myoma with edema
лечение миомы матки фокусированным ультразвуком под контролем магнитно-резонансной томографии
MRgFUS therapy of uterine myoma
Статья
The results of examinations and treatment of 349 patients with uterine myoma are analyzed. The patients were divided into 3 groups by the type of uterine myoma and clinical effi ciency of FUS therapy. Noninvasive dehydration of typical uterine myomas with edemas was used for extending the potentialities of MRgFUS and improvement of its results. Noninvasive lymph drainage was carried out in 42 patients with typical uterine myomas with stromal edemas. Dehydration led to shrinkage of the myoma nodule (by 20-40[%]) and attenuation of MR signal (by 50±15 U) in 85.7[%] (36) cases. Checkups 1, 3, 6, and 12 months after MRgFUS showed lesser intensity of uterine hemorrhages (according to PBAC tables), stable pain alleviation, and improvement of the quality of life (according to questionnaires).